KR950700289A - 퀴놀린-3-아세트산 유도체, 그의 제조법 및 용도(quinoline-3-acetic acid derivative, process for producing the same, and use thereof) - Google Patents

퀴놀린-3-아세트산 유도체, 그의 제조법 및 용도(quinoline-3-acetic acid derivative, process for producing the same, and use thereof)

Info

Publication number
KR950700289A
KR950700289A KR1019940703121A KR19940703121A KR950700289A KR 950700289 A KR950700289 A KR 950700289A KR 1019940703121 A KR1019940703121 A KR 1019940703121A KR 19940703121 A KR19940703121 A KR 19940703121A KR 950700289 A KR950700289 A KR 950700289A
Authority
KR
South Korea
Prior art keywords
quinoline
acetic acid
same
acid derivative
neurosis
Prior art date
Application number
KR1019940703121A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950700289A publication Critical patent/KR950700289A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
KR1019940703121A 1993-01-06 1994-09-06 퀴놀린-3-아세트산 유도체, 그의 제조법 및 용도(quinoline-3-acetic acid derivative, process for producing the same, and use thereof) KR950700289A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP01589993A JP3195455B2 (ja) 1993-01-06 1993-01-06 キノリン−３−酢酸誘導体、その製造法と用途
PCT/JP1994/000007 WO1994015934A1 (en) 1993-01-06 1994-01-06 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof

Publications (1)

Publication Number Publication Date
KR950700289A true KR950700289A (ko) 1995-01-16

Family

ID=11901633

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940703121A KR950700289A (ko) 1993-01-06 1994-09-06 퀴놀린-3-아세트산 유도체, 그의 제조법 및 용도(quinoline-3-acetic acid derivative, process for producing the same, and use thereof)

Country Status (12)

Country Link
US (1) US5543420A (ko)
EP (1) EP0633261B1 (ko)
JP (1) JP3195455B2 (ko)
KR (1) KR950700289A (ko)
CN (1) CN1102040A (ko)
AT (1) ATE179172T1 (ko)
AU (1) AU667426B2 (ko)
CA (1) CA2131370A1 (ko)
DE (1) DE69417957T2 (ko)
ES (1) ES2130403T3 (ko)
TW (1) TW287162B (ko)
WO (1) WO1994015934A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
CN101058558B (zh) * 2007-05-28 2013-04-10 沈阳药科大学 具有醛糖还原酶抑制活性的4-氧代-1(4h)-喹啉羧酸类化合物、组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703052A (en) * 1985-05-21 1987-10-27 Pfizer Inc. Hypoglycemic thiazolidinediones
JPS63270678A (ja) * 1987-04-30 1988-11-08 Mitsui Petrochem Ind Ltd 新規含窒素化合物
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
TW202450B (ko) * 1991-06-26 1993-03-21 Dainippon Pharmaceutical Co
US5262433A (en) * 1991-08-06 1993-11-16 Wakamoto Pharmaceutical Co., Ltd. Tetrazoleacetic acid derivatives and method of aldose reductase inhibition therewith

Also Published As

Publication number Publication date
CA2131370A1 (en) 1994-07-21
DE69417957D1 (de) 1999-05-27
EP0633261A1 (en) 1995-01-11
CN1102040A (zh) 1995-04-26
US5543420A (en) 1996-08-06
AU667426B2 (en) 1996-03-21
EP0633261A4 (en) 1995-04-12
EP0633261B1 (en) 1999-04-21
ATE179172T1 (de) 1999-05-15
JP3195455B2 (ja) 2001-08-06
TW287162B (ko) 1996-10-01
JPH06199851A (ja) 1994-07-19
DE69417957T2 (de) 1999-09-16
ES2130403T3 (es) 1999-07-01
WO1994015934A1 (en) 1994-07-21
AU5823394A (en) 1994-08-15

Similar Documents

Publication Publication Date Title
NO904202D0 (no) Terapeutisk aktive bifenylmetanderivater og fremgangsmaatefor deres fremstilling.
ES476496A1 (es) Procedimiento para preparar derivados de acido ftalazin-4- ilacetico.
FI943948A0 (fi) Heterosykliset hiilihappojohdannaiset
KR950700289A (ko) 퀴놀린-3-아세트산 유도체, 그의 제조법 및 용도(quinoline-3-acetic acid derivative, process for producing the same, and use thereof)
AU6291494A (en) Benzothiazole compound, process for producing the same, and use thereof
AU7238994A (en) Succinamic acid compound, process for producing the same, and use thereof
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
EP0644194A4 (en) COMPOUND BASED ON PYRIDOTHIAZINEACETIC ACID, PROCESS FOR PRODUCTION AND USE.
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
PL147875B1 (en) Method of obtaining derivatives of tetracyclic spirolohydantoine
EP0738727A4 (en) 1,4-BENZOXAZINE-2-ACETIC ACID COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF
DK0613897T3 (da) Piperidinderivater med anti-histamin-og anti-leukotrienaktivitet
WO1993005044A1 (en) Pyrazolotriazole derivative
MX9800368A (es) Derivados de piperidina de difenilmetileno.

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee